Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.
View original article
Contributor: Sheila Kaplan
Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.
View original article
Contributor: Sheila Kaplan